A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL

Clinical trial NCT05883709 · UNKNOWN

Trial details

NCT number: NCT05883709
Sponsor: Zhao Weili
Status: UNKNOWN
Study type: OBSERVATIONAL

Diffuse Large B-cell Lymphoma

Start date: 2023-07-01
Primary completion: 2023-12-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.